UI15AML055MT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UI15AML055MT, covering 2015-06-12 to 2015-06-12. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers [Phase 1]